Nature CommunicationsCombination of PARP and KRASG12D inhibitors enhances therapeutic efficacy by exploiting vulnerabilities in PDACXin XuXin ChenRongli XuZhenyu HuoChangying LiSomaira NowsheenKhaled AzizFan YaoZhenkun LouMin Deng2026-02-24Full textDOI https://doi.org/10.1038/s41467-026-69695-4